Fintel reports that on April 2, 2025, BTIG initiated coverage of NRx Pharmaceuticals (NasdaqCM:NRXP) with a Buy ...

Fintel reports that on March 31, 2025, BTIG upgraded their outlook for Progyny (NasdaqGS:PGNY) from Neutral to Buy. Analyst ...

In a "Liberation Day" spectacle at the White House, Trump uncorked a baseline tariff rate of 10% on countries that will go ...

BTIG initiated coverage of NRx Pharmaceuticals (NRXP) with a Buy rating and $18 price target NRx Pharmaceuticals is working broadly in ...

BTIG analysts highlighted a historical trend suggesting a potential rebound for the S&P 500 (SPX) in April following a ...

The S&P 500's recent breakdown below key technical levels suggests the market’s counter-trend rally may be over, said ...

BTIG says Rocket Companies (RKT) is acquiring Mr. Cooper (COOP) in an all-stock deal valuing Cooper at roughly $143 ore share, plus a $2 cash ...

Lululemon Athletica (NASDAQ:LULU – Free Report) had its price objective decreased by BTIG Research from $470.00 to $420.00 in ...

The S&P 500's (SP500) recent breakdown below key technical levels suggests the market’s counter-trend rally may be over, said Jonathan Krinsky, chief market technician at financial-services firm ...

On Monday, BTIG analysts maintained a Neutral rating on Venus Concept Inc. (NASDAQ:VERO) after the company reported lower-than-expected Q4 revenue. Venus Concept disclosed a quarterly revenue of $ ...